Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-10 5:08 pm Purchase | 2025-11-06 | 13D | MBX Biosciences, Inc. Common Stock MBX | New Enterprise Associates 17, L.P. | 3,619,474 8.100% | 4,988 (+0.14%) | Filing History |
| 2025-10-06 5:50 pm Sale | 2025-10-02 | 13D | NeueHealth, Inc. NEUE | New Enterprise Associates 17, L.P. | 0 0.000% | -7,360,329 (Position Closed) | Filing History |
| 2025-05-07 8:03 pm Purchase | 2025-05-07 | 13D | Inventiva S.A. IVA | New Enterprise Associates 17, L.P. | 8,350,730 6.000% | 514,846 (+6.57%) | Filing History |
| 2024-12-26 3:09 pm Purchase | 2024-12-23 | 13D | NeueHealth, Inc. NEUE | New Enterprise Associates 17, L.P. | 7,360,329 57.000% | 7,360,329 (New Position) | Filing History |
| 2024-10-21 8:54 pm Purchase | 2024-10-17 | 13D | Inventiva S.A. IVA | New Enterprise Associates 17, L.P. | 7,835,884 9.000% | 2,262,931 (+40.61%) | Filing History |
| 2024-09-23 6:05 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | New Enterprise Associates 17, L.P. | 3,614,486 11.400% | 3,614,486 (New Position) | Filing History |
| 2024-08-12 7:46 pm Sale | 2024-08-08 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,774,930 12.700% | -10,000 (-0.13%) | Filing History |
| 2024-05-13 8:40 pm Purchase | 2024-05-09 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,784,930 15.400% | 7,784,930 (New Position) | Filing History |
| 2024-05-03 9:22 pm Purchase | 2024-04-03 | 13D | Inventiva S.A. IVA | New Enterprise Associates 17, L.P. | 5,572,953 10.700% | 420,920 (+8.17%) | Filing History |
| 2024-04-24 7:33 pm Purchase | 2024-04-22 | 13D | Korro Bio, Inc. KRRO | New Enterprise Associates 17, L.P. | 1,096,125 11.800% | 17,857 (+1.66%) | Filing History |
| 2023-11-17 12:38 pm Purchase | 2023-11-03 | 13D | Korro Bio, Inc. KRRO | New Enterprise Associates 17, L.P. | 1,078,268 13.400% | 1,078,268 (New Position) | Filing History |
| 2021-07-26 2:49 pm Purchase | 2021-06-28 | 13D | Bright Health Group, Inc. BHG | New Enterprise Associates 17, L.P. | 2,726,920 35.500% | 2,726,920 (New Position) | Filing History |
| 2021-07-12 3:49 pm Purchase | 2021-06-28 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,694,916 17.300% | 7,694,916 (New Position) | Filing History |